Purpose: To evaluate the clinical outcome of transscleral cy-clophotocoagulation (TSCPC) with diode laser in high risk glaucomas as a primary treatment Methods: A prospectively study was done of 15 patients (17 eyes) ...Purpose: To evaluate the clinical outcome of transscleral cy-clophotocoagulation (TSCPC) with diode laser in high risk glaucomas as a primary treatment Methods: A prospectively study was done of 15 patients (17 eyes) with different glaucomas. Average age 55years. Follow-up ranged from 6 to 36 months. Most of the patients had neovascular glaucoma (13eyes), chronic展开更多
文摘Purpose: To evaluate the clinical outcome of transscleral cy-clophotocoagulation (TSCPC) with diode laser in high risk glaucomas as a primary treatment Methods: A prospectively study was done of 15 patients (17 eyes) with different glaucomas. Average age 55years. Follow-up ranged from 6 to 36 months. Most of the patients had neovascular glaucoma (13eyes), chronic
